Literature DB >> 24512410

Severe spinal cord ischemic injury secondary to device embolization after transcatheter closure of a patent arterial duct.

Liang Tang1, Shenghua Zhou, Xiangqian Shen.   

Abstract

Percutaneous closure of patent arterial ducts with the Amplatzer Ductal Occluder has become an effective and widely accepted alternative to surgical management. Although rarely, the occluder can be dislodged after an initially successful deployment, and with catastrophic consequences. We describe such a case in a 12-month-old girl who underwent transcatheter closure of a patent arterial duct. After device deployment, the occluder embolized in the patient's descending thoracic aorta, and severe spinal cord ischemic injury resulted. To our knowledge, ours is the first report of this complication after the deployment of an Amplatzer Ductal Occluder. We discuss pathophysiologic mechanisms that could expose patients to the risk of device dislodgment, and we review the relevant medical literature.

Entities:  

Mesh:

Year:  2014        PMID: 24512410      PMCID: PMC3967470          DOI: 10.14503/THIJ-12-2927

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  13 in total

1.  Closure of the patent ductus arteriosus with the amplatzer PDA device: immediate results of the international clinical trial.

Authors:  H J Faella; Z M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2000-09       Impact factor: 2.692

Review 2.  Embolization and transcatheter retrieval of coils and devices.

Authors:  C A Tan; D S Levi; J W Moore
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

3.  Late embolization of Amplatzer patent ductus arteriosus occlusion device with thoracic aorta embedment.

Authors:  David Michael McMullan; Achintya Moulick; Richard A Jonas
Journal:  Ann Thorac Surg       Date:  2007-03       Impact factor: 4.330

4.  The Amplatzer duct occluder: experience in 209 patients.

Authors:  A A Bilkis; M Alwi; S Hasri; A L Haifa; K Geetha; M A Rehman; I Hasanah
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

5.  Surgical rescue of embolized amplatzer devices.

Authors:  Muneer M Amanullah; Maria T Siddiqui; Mubashir Z Khan; Mehnaz A Atiq
Journal:  J Card Surg       Date:  2011-04-11       Impact factor: 1.620

6.  Paraplegia following percutaneous balloon angioplasty of aortic coarctation: a case report.

Authors:  G P Ussia; M Marasini; G Pongiglione
Journal:  Catheter Cardiovasc Interv       Date:  2001-12       Impact factor: 2.692

7.  Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders.

Authors:  Jozef Masura; Peter Tittel; Pavol Gavora; Tomaz Podnar
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

8.  Spinal cord damage and operations for coarctation of the aorta: aetiology, practice, and prospects.

Authors:  G Keen
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

9.  Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results.

Authors:  Robert H Pass; Ziyad Hijazi; Daphne T Hsu; Veronica Lewis; William E Hellenbrand
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

10.  Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct.

Authors:  Jonathan Forsey; Damien Kenny; Gareth Morgan; Alison Hayes; Mark Turner; Andrew Tometzki; Robin Martin
Journal:  Catheter Cardiovasc Interv       Date:  2009-10-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.